4//SEC Filing
Westphal Christoph H 4
Accession 0000899243-21-029479
CIK 0001783328other
Filed
Jul 21, 8:00 PM ET
Accepted
Jul 22, 4:46 PM ET
Size
16.1 KB
Accession
0000899243-21-029479
Insider Transaction Report
Form 4
Westphal Christoph H
Director10% Owner
Transactions
- Purchase
Voting Common Stock
2021-07-20$15.00/sh+133,333$1,999,995→ 1,278,838 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-07-20−641,848→ 0 total(indirect: See footnote)→ Voting Common Stock (641,848 underlying) - Conversion
Series B Preferred Stock
2021-07-20−332,594→ 0 total(indirect: See footnote)→ Voting Common Stock (332,594 underlying) - Conversion
Voting Common Stock
2021-07-20+1,145,505→ 1,145,505 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2021-07-20−171,063→ 0 total(indirect: See footnote)→ Voting Common Stock (171,063 underlying)
Holdings
- 914,634
Voting Common Stock
- 121,951(indirect: See footnote)
Voting Common Stock
Footnotes (4)
- [F1]These shares are held by the Reporting Person's spouse.
- [F2]Each share of the Issuer's preferred stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.
- [F3]These shares are held by Longwood Fund IV, L.P. ("Longwood"). The general partner of Longwood is Longwood Fund IV GP, LLC ("Longwood GP"). Voting, investment and dispositive decisions at Longwood GP with respect to the securities held by Longwood are made by an investment committee comprised of Christoph Westphal, Richard Aldrich and John Lawrence (collectively, the "IC Members"). Longwood GP and each of the IC Members may be deemed to share voting, investment and dispositive power over the securities held by Longwood and as a result may be deemed to have beneficial ownership over such securities. Longwood GP and each of the IC Members disclaims beneficial ownership over the securities held by Longwood, except to the extent of their respective pecuniary interests therein.
- [F4]Represents shares purchased in the Issuer's initial public offering.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0001291961
Filing Metadata
- Form type
- 4
- Filed
- Jul 21, 8:00 PM ET
- Accepted
- Jul 22, 4:46 PM ET
- Size
- 16.1 KB